Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants
Status:
Completed
Trial end date:
2023-08-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the effect of a strong inhibitor of CYP3A4
(itraconazole) on the pharmacokinetics (PK) of GST-HG171/ritonavir in healthy participants.